Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Kerrie Gosney brings you Sunday night's forecast
Cold with wintry showers overnight and on Monday.
Cold air from Canada will turn showers wintry overnight into Monday morning. Snow could settle over higher routes. Icy patches possible